ONCLIVE NEWS NETWORK: ON LOCATION WILL BE LIVE AT ESMO THIS WEEK - STAY TUNED FOR MORE INFORMATION!

Dr. Infante Talks About BRAF Mutation Testing

Jeffrey R. Infante, MD
Published: Tuesday, Jun 07, 2011

Jeffrey Infante, MD, director of drug development at the Sarah Cannon Research Institute talks about BRAF mutation testing.

Dr. Infante says that there is a subset of melanoma patients (about half) that have the BRAF mutation. He adds it can be tested easily around the country by multiple labs. If it turns out that a patient has a genetic change that is a BRAF mutation, there are drugs that can help the patient. While the drugs aren't FDA approved yet, there are many trials ongoing where patients can get access to those drugs.
Jeffrey Infante, MD, director of drug development at the Sarah Cannon Research Institute talks about BRAF mutation testing.

Dr. Infante says that there is a subset of melanoma patients (about half) that have the BRAF mutation. He adds it can be tested easily around the country by multiple labs. If it turns out that a patient has a genetic change that is a BRAF mutation, there are drugs that can help the patient. While the drugs aren't FDA approved yet, there are many trials ongoing where patients can get access to those drugs.

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 18th Annual International Lung Cancer Congress®Oct 31, 20181.5
Provider and Caregiver Connection™: Addressing Patient Concerns While Managing Chemotherapy Induced Nausea and VomitingOct 31, 20182.0
Publication Bottom Border
Border Publication
x